MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bellerophon Therapeutics Company Profile (NASDAQ:BLPH)

Consensus Ratings for Bellerophon Therapeutics (NASDAQ:BLPH) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (796.36% upside)

Analysts' Ratings History for Bellerophon Therapeutics (NASDAQ:BLPH)
Show:
DateFirmActionRatingPrice TargetActions
3/24/2016Cowen and CompanyInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016FBR & Co.Reiterated RatingOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016Leerink SwannLower Price TargetOutperform$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015SunTrustInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha